176 related articles for article (PubMed ID: 36386154)
21. ADAM12 induces estrogen-independence in breast cancer cells.
Roy R; Moses MA
Breast Cancer Res Treat; 2012 Feb; 131(3):731-41. PubMed ID: 21387162
[TBL] [Abstract][Full Text] [Related]
22. Antiestrogen-resistant human breast cancer cells require activated protein kinase B/Akt for growth.
Frogne T; Jepsen JS; Larsen SS; Fog CK; Brockdorff BL; Lykkesfeldt AE
Endocr Relat Cancer; 2005 Sep; 12(3):599-614. PubMed ID: 16172194
[TBL] [Abstract][Full Text] [Related]
23. Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.
Ito T; Kamijo S; Izumi H; Kohno K; Amano J; Ito K
Breast Cancer Res Treat; 2012 May; 133(1):145-59. PubMed ID: 21863258
[TBL] [Abstract][Full Text] [Related]
24. Increased expression of the HDAC9 gene is associated with antiestrogen resistance of breast cancers.
Linares A; Assou S; Lapierre M; Thouennon E; Duraffourd C; Fromaget C; Boulahtouf A; Tian G; Ji J; Sahin O; Badia E; Boulle N; Cavaillès V
Mol Oncol; 2019 Jul; 13(7):1534-1547. PubMed ID: 31099456
[TBL] [Abstract][Full Text] [Related]
25. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
[TBL] [Abstract][Full Text] [Related]
26. Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifen.
Herman ME; Katzenellenbogen BS
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):121-34. PubMed ID: 9010327
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
Juncker-Jensen A; Lykkesfeldt AE; Worm J; Ralfkiaer U; Espelund U; Jepsen JS
Growth Horm IGF Res; 2006 Aug; 16(4):224-39. PubMed ID: 16893667
[TBL] [Abstract][Full Text] [Related]
28. Stabilization of MORC2 by estrogen and antiestrogens through GPER1- PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells.
Yang F; Xie HY; Yang LF; Zhang L; Zhang FL; Liu HY; Li DQ; Shao ZM
Autophagy; 2020 Jun; 16(6):1061-1076. PubMed ID: 32401166
[TBL] [Abstract][Full Text] [Related]
29. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
Santos-Martínez N; Díaz L; Ordaz-Rosado D; García-Quiroz J; Barrera D; Avila E; Halhali A; Medina-Franco H; Ibarra-Sánchez MJ; Esparza-López J; Camacho J; Larrea F; García-Becerra R
BMC Cancer; 2014 Mar; 14():230. PubMed ID: 24678876
[TBL] [Abstract][Full Text] [Related]
30. Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments.
Ao A; Morrison BJ; Wang H; López JA; Reynolds BA; Lu J
PLoS One; 2011 Apr; 6(4):e18810. PubMed ID: 21533195
[TBL] [Abstract][Full Text] [Related]
31. EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometrium.
Labrie F; Labrie C; Bélanger A; Simard J; Gauthier S; Luu-The V; Mérand Y; Giguere V; Candas B; Luo S; Martel C; Singh SM; Fournier M; Coquet A; Richard V; Charbonneau R; Charpenet G; Tremblay A; Tremblay G; Cusan L; Veilleux R
J Steroid Biochem Mol Biol; 1999; 69(1-6):51-84. PubMed ID: 10418981
[TBL] [Abstract][Full Text] [Related]
32. Hyaluronate synthase-2 overexpression alters estrogen dependence and induces histone deacetylase inhibitor-like effects on ER-driven genes in MCF7 breast tumor cells.
Vanneste M; Hanoux V; Bouakka M; Bonnamy PJ
Mol Cell Endocrinol; 2017 Mar; 444():48-58. PubMed ID: 28137613
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer.
Zhao M; Ramaswamy B
World J Clin Oncol; 2014 Aug; 5(3):248-62. PubMed ID: 25114842
[TBL] [Abstract][Full Text] [Related]
34. Next-Generation ERα Inhibitors for Endocrine-Resistant ER+ Breast Cancer.
Fanning SW; Greene GL
Endocrinology; 2019 Apr; 160(4):759-769. PubMed ID: 30753408
[TBL] [Abstract][Full Text] [Related]
35. Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms.
Li H; Gao C; Liang Q; Liu C; Liu L; Zhuang J; Yang J; Zhou C; Feng F; Sun C
Front Pharmacol; 2020; 11():592109. PubMed ID: 33505309
[No Abstract] [Full Text] [Related]
36. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
[No Abstract] [Full Text] [Related]
37. Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.
Gururaj AE; Rayala SK; Vadlamudi RK; Kumar R
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1001s-1007s. PubMed ID: 16467116
[TBL] [Abstract][Full Text] [Related]
38. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
Montano MM; Jaiswal AK; Katzenellenbogen BS
J Biol Chem; 1998 Sep; 273(39):25443-9. PubMed ID: 9738013
[TBL] [Abstract][Full Text] [Related]
40. Molecular and pharmacological aspects of antiestrogen resistance.
Clarke R; Skaar TC; Bouker KB; Davis N; Lee YR; Welch JN; Leonessa F
J Steroid Biochem Mol Biol; 2001; 76(1-5):71-84. PubMed ID: 11384865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
